Pfizer Ltd. — Regulatory Filings 2020

Jan 10, 2020

==> picture [65 x 39] intentionally omitted <==

==> picture [117 x 31] intentionally omitted <==

==> picture [118 x 25] intentionally omitted <==

KFIN/PFZ/DEC/2019 January 8, 2020

Mr. Prajeet Nair Company Secretary M/s. Pfizer Limited The Capital, 1802/1901 Plot C-70 G Block, BandraKurla Complex Bandra East, Mumbai- 400051

Sub : Confirmation Certificate in the matter of Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Dear Sir/Madam,

Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we hereby confirm that the securities received from the depository participants for dematerialisation during the quarter ended December 31, 2019, were confirmed (accepted / rejected) to the depositories by us and the securities comprised in the said certificates have been listed on stock exchanges where the earlier issued securities are listed.

We also hereby confirm that the security certificates received for dematerialisation have been mutilated and cancelled after due verification by the depository participant and the name of the depositories have been substituted in register of members as the registered owner within 30 days.

Request to kindly take the above on record

Thanking You

Yours faithfully, for KFin Technologies Private Limited

==> picture [50 x 25] intentionally omitted <==

M R V Subrahmanyam General Manager

KFin Technologies Private Limited

(Formerly known as Karvy Fintech Private Limited)

Registered & Corporate Office

“Selenium Tower-B”, Plot No. 31 & 32, Gachibowli, Financial District, Nanakramguda, Serilingampally, Hyderabad - 500032, Telangana.

Ph. : +91 40 6716 2222, 3321 1000 | www.kfintech.com | CIN : U72400TG2017PTC117649